Enhanced estrogen-induced proliferation in obese rat endometrium

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 2, 2009, Pages 186.e1-186.e8

  Zhang, Qian ^a   Shen, Qi ^b   Celestino, Joseph ^a   Milam, Michael R ^a   Westin, Shannon N ^a   Lacour, Robin A ^a   Meyer, Larissa A ^a   Shipley, Gregory L ^b   Davies, Peter J A ^b   Deng, Lei ^a   McCampbell, Adrienne S ^a   Broaddus, Russell R ^a   Lu, Karen H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

endometrial; estrogen; obesity; proliferation

Indexed keywords

CYCLIN A; ESTRADIOL; RETINAL DEHYDROGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM CELL; FEMALE; GENE EXPRESSION; IMMUNOBLOTTING; INSULIN SENSITIVITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; ONCOGENE C MYC; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 58749115813     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.08.064     Document Type: Article

References (29)

1. McCourt C.K., Mutch D.G., Gibb R.K., et al. Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometria cancer. Gynecol Oncol 104 (2007) 535-539
2. Schottenfeld D. Epidemiology of endometrial neoplasia. J Cell Biochem Suppl 23 (1995) 151-159
3. Pettersson B., Bergstrom R., and Johansson E.D. Serum estrogens and androgens in women with endometrial carcinoma. Gynecol Oncol 25 (1986) 223-233
4. Potischman N., Hoover R.N., Brinton L.A., et al. Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 88 (1996) 1127-1135
5. Friberg E., Mantzoros C.S., and Wolk A. Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev 16 (2007) 276-280
6. Zhuang Y.H., Sarca D., Weisz A., et al. Cell type-specific induction of cyclin D and cyclin-dependent kinase inhibitor p27Kip1 expression by estrogen in rat endometrium. J Steroid Biochem Mol Bio 78 (2001) 193-199
7. Shah Y.M., Al-Dhaheri M., Dong Y., Ip C., Jones F.E., and Rowan B.G. Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells. Mol Cancer Ther 4 (2005) 1239-1249
8. Rosenberg A.R., Zindy F., Le Deist F., et al. Overexpression of human cyclin A advances entry into S phase. Oncogene 10 (1995) 1501
9. Heikkila R., Schwab G., Wickstrom E., et al. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature 328 (1987) 445-449
10. Baluchamy S., Sankar N., Navaraj A., Moran E., and Thimmapaya B. Relationship between E1A binding to cellular proteins, c-myc activation and S-phase induction. Oncogene 26 (2007) 781-787
11. Watanabe J., Kamata Y., Seo N., Okayasu I., and Kuramoto H. Stimulatory effect of estrogen on the growth of endometrial cancer cells is regulated by cell-cycle regulators. J Steroid Biochem Mol Biol 107 (2007) 163-171
12. Erkanli S., Kayaselcuk F., Kuscu E., et al. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium. Int J Gynecol Cancer 16 (2006) 1412-1418
13. Fujita M., Ogawa S., Fukuoka H., et al. Differential expression of secreted frizzled-related protein 4 in decidual cells during pregancy. J Mol Endocrinol 28 (2002) 213-223
14. Holinka C.F., Hata H., Kuramoto H., and Gurpide E. Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa). J Steroid Biochem 24 (1986) 85-89
15. Hata H., and Kuramoto H. Immunocytochemical determination of estrogen and progesterone receptors in human endometrial adenocarcinoma cells (Ishikawa cells). J Steroid Biochem Mol Biol 42 (1992) 201-210
16. Deng L., Shipley G.L., Loose-Mitchell D.S., et al. Coordinate regulation of the production and signaling of retinoic acid by estrogen in the human endometrium. J Clin Endocrinol Metab 88 (2002) 2157-2163
17. Zucker L.M., and Antoniades H.N. Insulin and obesity in the Zucker genetically obese rat ("fatty"). Endocrinology 90 (1972) 1320-1330
18. Stern J., Johnson P.R., Greenwood M.R., Zucker L.M., and Hirsch J. Insulin resistance and pancreatic insulin release in the genetically obese Zucker rat. Proc Soc Exp Biol Med 139 (1972) 66-69
19. Bray G.A. The Zucker-fatty rat: a review. Fed Proc 36 (1977) 148-153
20. Shen Q., Cline G.W., Shulman G.I., Leibowitz M.D., and Davies P.J. Effects of rexinoids on glucose transport and insulin-mediated signaling in skeletal muscles of diabetic (db/db) mice. J Biol Chem 279 (2004) 19721-19731
21. Suzuki A., Urushitani H., Watanabe H., et al. Comparison of estrogen responsive genes in the mouse uterus, vagina, and mammary gland. J Vet Med Sci 69 (2007) 725-731
22. Hrzenjak A., Tippl M., Kremser M.L., et al. Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcomas. J Pathol 204 (2004) 19-27
23. Horvath L.G., Lelliott J.E., Kench J.G., et al. Secreted frizzled-related proten 4 inhibits proliferation and metastatic potential in prostate cancer. Prostate 67 (2007) 1081-1090
24. Ruhl R., Fritzsche B., Vermot J., et al. Regulation of expression of the retinoic acid-synthesising enzymes retinaldehyde dehydrogenases in the uterus of ovariectomised mice after treatment with oestrogen, gestagen and their combination. Reprod Fertil Dev 18 (2006) 339-345
25. Gentilini D., Busacca M., Di Francesco S., Vignali M., Viganò P., and Di Blasio A.M. PI3K/Akt and ERK1/2 signaling pathways are involved in endometrial cell migration induced by 17beta-estradiol and growth factors. Mol Hum Reprod 13 (2007) 317-322
26. Dunn K.L., Espino P.S., Drobic B., He S., and Davie J.R. The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem Cell 83 (2005) 1-14
27. Yoon S., and Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24 (2006) 21-44
28. Ivanga M., Labrie Y., Calvo E., et al. Temporal analysis of E2 transcriptional induction of PTP and MKP and downregulation of IGF-I pathway key components in the mouse uterus. Physiol Genomics 29 (2007) 13-23
29. Chuang C.F., and Ng S.Y. Functional divergence of the MAP kinase pathway ERK1 and ERK2 activate specific transcription factors. FEBS Lett 346 (1994) 229-234